Mika K Kaneko

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 35

Top Venues

International journal of molecular sciences

Antibodies (Basel, Switzerland)

Nature communications

Current issues in molecular biology

Tohoku Univesity

Graduate University For Advanced Studies (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tohoku Univesity Apr 01 2012

Japan

Associate Professor :: Department of Antibody Drug Development

Yamagata University Apr 01 2010 - Mar 31 2012

Japan

Assistant Professor :: Molecular Tumor Marker Research Team

Duke University Medical Center Mar 01 2009 - Mar 31 2010

United States

Senior Research Associate :: Department of Pathology

National Institute Advanced Industrial Science and Technology Apr 01 2006 - Mar 31 2008

Japan

Postdoctoral Fellow :: Research Center for Medical Glycoscience

Tokyo Metropolitan Institute of Neuroscience Apr 01 2005 - Mar 31 2006

Japan

Postdoctoral Fellow :: Department of Molecular Developmental Biology

Yamagata University School of Medicine Apr 01 2000 - Mar 31 2005

Japan

Assistant Professor :: Department of Experimental and Forensic Pathology

University of Georgia Sep 01 2002 - Aug 31 2003

United States

Postdoctoral Fellow :: Department of Biochemistry and Molecular Biology

Education History

Graduate University For Advanced Studies Apr 01 1997 - Mar 31 2000

Japan

PHD :: Department of Genetics, School of Life Science

Publications

Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Anti-HER2 Cancer-Specific mAb, H 2 Mab-250-hG 1 , Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. International journal of molecular sciences 25 (15) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Kenichiro Ishikawa, Hiroyuki Suzuki, Tomokazu Ohishi, Guanjie Li, Tomohiro Tanaka, Manabu Kawada, Akira Ohkoshi, Mika K Kaneko, Yukio Katori, Yukinari Kato
Anti-CD44 Variant 10 Monoclonal Antibody Exerts Antitumor Activity in Mouse Xenograft Models of Oral Squamous Cell Carcinomas. International journal of molecular sciences 25 (17) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Hiroyuki Suzuki, Tomokazu Ohishi, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Anti-HER2 Cancer-Specific mAb, H 2 Mab-250-hG 1 , Possesses Higher Complement-Dependent Cytotoxicity than Trastuzumab. International journal of molecular sciences 25 (15) (2024)
Mika K Kaneko, Hiroyuki Suzuki, Tomokazu Ohishi, Takuro Nakamura, Tomohiro Tanaka, Yukinari Kato
A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models. International journal of molecular sciences 25 (3) (2024)
Kohdai Yamada, Ryouhei Shioya, Kohei Nishino, Hirotake Furihata, Atsushi Hijikata, Mika K Kaneko, Yukinari Kato, Tsuyoshi Shirai, Hidetaka Kosako, Tatsuya Sawasaki
Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding. Nature communications 14 (1) (2023)
Mayuki Tawara, Hiroyuki Suzuki, Nohara Goto, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
A Novel Anti-CD44 Variant 9 Monoclonal Antibody C 44 Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers. Current issues in molecular biology 45 (4) (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Ren Nanamiya, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Defucosylated Monoclonal Antibody (H 2 Mab-139-mG 2a -f) Exerted Antitumor Activities in Mouse Xenograft Models of Breast Cancers against Human Epidermal Growth Factor Receptor 2. Current issues in molecular biology 45 (10) (2023)
Tomohiro Tanaka, Mayuki Tawara, Hiroyuki Suzuki, Mika K Kaneko, Yukinari Kato
Identification of the Binding Epitope of an Anti-Mouse CCR6 Monoclonal Antibody (C 6 Mab-13) Using 1× Alanine Scanning. Antibodies (Basel, Switzerland) 12 (2) (2023)
Kohdai Yamada, Ryouhei Shioya, Kohei Nishino, Hirotake Furihata, Atsushi Hijikata, Mika K Kaneko, Yukinari Kato, Tsuyoshi Shirai, Hidetaka Kosako, Tatsuya Sawasaki
Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding. Nature communications 14 (1) (2023)
Hiroyuki Suzuki, Tomokazu Ohishi, Mika K Kaneko, Yukinari Kato
A Humanized and Defucosylated Antibody against Podoplanin (humLpMab-23-f) Exerts Antitumor Activities in Human Lung Cancer and Glioblastoma Xenograft Models. Cancers 15 (20) (2023)
Hiroyuki Suzuki, Kazuki Ozawa, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C 44 Mab-34, for Multiple Applications against Oral Carcinomas. Biomedicines 11 (4) (2023)
Kohdai Yamada, Ryouhei Shioya, Kohei Nishino, Hirotake Furihata, Atsushi Hijikata, Mika K Kaneko, Yukinari Kato, Tsuyoshi Shirai, Hidetaka Kosako, Tatsuya Sawasaki
Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding. Nature communications 14 (1) (2023)
Yuma Kudo, Hiroyuki Suzuki, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Development of a Novel Anti-CD44 Variant 5 Monoclonal Antibody C 44 Mab-3 for Multiple Applications against Pancreatic Carcinomas. Antibodies (Basel, Switzerland) 12 (2) (2023)
Mayuki Tawara, Hiroyuki Suzuki, Nohara Goto, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
A Novel Anti-CD44 Variant 9 Monoclonal Antibody C 44 Mab-1 Was Developed for Immunohistochemical Analyses against Colorectal Cancers. Current issues in molecular biology 45 (4) (2023)
Kohdai Yamada, Ryouhei Shioya, Kohei Nishino, Hirotake Furihata, Atsushi Hijikata, Mika K Kaneko, Yukinari Kato, Tsuyoshi Shirai, Hidetaka Kosako, Tatsuya Sawasaki
Proximity extracellular protein-protein interaction analysis of EGFR using AirID-conjugated fragment of antigen binding. Nature communications 14 (1) (2023)
Hiroyuki Suzuki, Kazuki Ozawa, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato
Development of a Novel Anti-CD44 Variant 7/8 Monoclonal Antibody, C 44 Mab-34, for Multiple Applications against Oral Carcinomas. Biomedicines 11 (4) (2023)
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K Kaneko, Yukinari Kato
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model. Antibodies (Basel, Switzerland) 11 (4) (2022)
Guanjie Li, Hiroyuki Suzuki, Teizo Asano, Tomohiro Tanaka, Hiroyoshi Suzuki, Mika K Kaneko, Yukinari Kato
Development of a Novel Anti-EpCAM Monoclonal Antibody for Various Applications. Antibodies (Basel, Switzerland) 11 (2) (2022)
Shohei Nosaki, Mika K Kaneko, Fuminori Tsuruta, Hideki Yoshida, Yukinari Kato, Kenji Miura
Prevention of necrosis caused by transient expression in Nicotiana benthamiana by application of ascorbic acid. Plant physiology 186 (2) (2022)
Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, Mana Murae, Masayoshi Fukasawa, Mika K Kaneko, Yukinari Kato, Kohji Noguchi
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. International journal of molecular sciences 23 (24) (2022)
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K Kaneko, Yukinari Kato
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model. Antibodies (Basel, Switzerland) 11 (4) (2022)
Akihiro Ishikawa, Masazumi Waseda, Tomoko Ishii, Mika K Kaneko, Yukinari Kato, Shin Kaneko
Improved anti-solid tumor response by humanized anti-podoplanin chimeric antigen receptor transduced human cytotoxic T cells in an animal model. Genes to cells : devoted to molecular & cellular mechanisms 27 (9) (2022)
Teizo Asano, Tomohiro Tanaka, Hiroyuki Suzuki, Guanjie Li, Tomokazu Ohishi, Manabu Kawada, Takeo Yoshikawa, Mika K Kaneko, Yukinari Kato
A Defucosylated Anti-EpCAM Monoclonal Antibody (EpMab-37-mG 2a -f) Exerts Antitumor Activity in Xenograft Model. Antibodies (Basel, Switzerland) 11 (4) (2022)
Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, Mana Murae, Masayoshi Fukasawa, Mika K Kaneko, Yukinari Kato, Kohji Noguchi
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. International journal of molecular sciences 23 (24) (2022)
Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, Mana Murae, Masayoshi Fukasawa, Mika K Kaneko, Yukinari Kato, Kohji Noguchi
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. International journal of molecular sciences 23 (24) (2022)
Nami Tateyama, Hiroyuki Suzuki, Tomokazu Ohishi, Teizo Asano, Tomohiro Tanaka, Takuya Mizuno, Takeo Yoshikawa, Manabu Kawada, Mika K Kaneko, Yukinari Kato
Antitumor Activity of an Anti-EGFR/HER2 Bispecific Antibody in a Mouse Xenograft Model of Canine Osteosarcoma. Pharmaceutics 14 (11) (2022)
Yuichiro Yamamoto, Tetsuya Inoue, Miyu Inoue, Mana Murae, Masayoshi Fukasawa, Mika K Kaneko, Yukinari Kato, Kohji Noguchi
SARS-CoV-2 Spike Protein Mutation at Cysteine-488 Impairs Its Golgi Localization and Intracellular S1/S2 Processing. International journal of molecular sciences 23 (24) (2022)
Yuki Imaizumi, Kazunori Takanuki, Takuya Miyake, Mizuki Takemoto, Kunio Hirata, Mika Hirose, Rika Oi, Tatsuya Kobayashi, Kenichi Miyoshi, Rie Aruga, Tatsuhiko Yokoyama, Shizuka Katagiri, Hiroaki Matsuura, Kenji Iwasaki, Takayuki Kato, Mika K Kaneko, Yukinari Kato, Michiko Tajiri, Satoko Akashi, Osamu Nureki, Yohei Hizukuri, Yoshinori Akiyama, Terukazu Nogi
Mechanistic insights into intramembrane proteolysis by E. coli site-2 protease homolog RseP. Science advances 8 (34) (2022)
Takuya Mizuno, Yukinari Kato, Mika K Kaneko, Yusuke Sakai, Toshinori Shiga, Masahiro Kato, Toshihiro Tsukui, Hirofumi Takemoto, Akio Tokimasa, Kenji Baba, Yuki Nemoto, Osamu Sakai, Masaya Igase
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment. Scientific reports 10 (1) (2020)
Mami Yasukawa, Yoshinari Ando, Taro Yamashita, Yoko Matsuda, Shisako Shoji, Masaki Suimye Morioka, Hideya Kawaji, Kumiko Shiozawa, Mitsuhiro Machitani, Takaya Abe, Shinji Yamada, Mika K Kaneko, Yukinari Kato, Yasuhide Furuta, Tadashi Kondo, Mikako Shirouzu, Yoshihide Hayashizaki, Shuichi Kaneko, Kenkichi Masutomi
CDK1 dependent phosphorylation of hTERT contributes to cancer progression. Nature communications 11 (1) (2020)

Mika K Kaneko.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mika K Kaneko